Table 2.
Characteristic | Minimally invasive pyeloplasty vs. endopyelotomy | Minimally invasive pyeloplasty vs. open pyeloplasty | Endopyelotomy vs. open pyeloplasty |
---|---|---|---|
Treatment type | |||
Minimally invasive pyeloplasty | 0.52 (0.39–0.69) | 0.98 (0.68–1.42) | -- |
Open pyeloplasty | -- | 1 | 1 |
Endopyelotomy | 1 | -- | 1.78 (1.33–2.37) |
Age | 1.00 (0.99–1.01) | 1.01 (0.99–1.02) | 0.99 (0.99–1.01) |
Gender | |||
Female | 1 | 1 | 1 |
Male | 1.13 (0.89–1.44) | 1.23 (0.87–1.74) | 0.99 (0.78–1.26) |
Comorbidity | |||
0 | 1 | 1 | 1 |
1 or more | 1.30 (0.97–1.80) | 1.35 (0.85–2.15) | 1.37 (1.01–1.86) |
Benefit plan type | |||
HMO | 1 | 1 | 1 |
PPO | 1.05 (0.74–1.50) | 1.20 (0.69–2.09) | 1.17 (0.81–1.70) |
Other** | 1.15 (0.76–1.74) | 1.13 (0.59–2.16) | 1.17 (0.76–1.79) |
Employment classification | |||
Non-salaried | 1 | 1 | 1 |
Salaried | 0.97 (0.67–1.40) | 1.21 (0.72–2.05) | 0.85 (0.58–1.26) |
Unknown | 0.92 (0.67–1.27) | 1.40 (0.85–2.32) | 0.94 (0.68–1.30) |
Employment status | |||
Non-full time | 1 | 1 | 1 |
Full time | 0.81 (0.60–1.09) | 1.14 (0.74–1.75) | 0.92 (0.68–1.23) |
Region of residence | |||
Northeast | 1 | 1 | 1 |
North Central | 1.26 (0.77–2.06) | 1.24 (0.66–2.34) | 0.83 (0.52–1.32) |
South | 1.73 (1.11–2.70) | 1.38 (0.75–2.54) | 1.15 (0.77–1.71) |
West | 1.70 (1.02–2.81) | 1.58 (0.79–3.15) | 1.04 (0.65–1.67) |
Unknown | 2.07 (0.71–6.04) | 0 (0–>100) | 1.33 (0.46–3.79) |
Patient MSA | 1.22 (0.87–1.70) | 1.25 (0.75–2.09) | 1.36 (0.96–1.92) |
Provider MSA | 0.80 (0.53–1.20) | 1.23 (0.59–2.56) | 0.92 (0.60–1.40) |
Treatment year | 0.97 (0.92–1.02) | 0.90 (0.83–0.97) | 0.97 (0.92–1.03) |
Abbreviations: CI, confidence interval; HMO, health maintenance organization; MSA, metropolitan statistical area; PPO, preferred provider organization
The effect of each predictor was adjusted for all other predictors in the model
Other includes comprehensive, exclusive provider organization, point of service, point of service with capitation, consumer directed health plan, and missing